Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double-blind, 8-week study-Reference-Cited by-同舟云学术

Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double-blind, 8-week study

Published:2018-01 Issue:1 Volume:20 Page:150-158
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:J Clin Hypertens

Author:

Cheung Deanna G.¹,Aizenberg Diego²,Gorbunov Vladimir³,Hafeez Kudsia⁴,Chen Chien-Wei⁴,Zhang Jack⁵

Affiliation:

1. Long Beach Center for Clinical Research; Long Beach CA USA

2. Centro Medico Viamonte; Buenos Aires Argentina

3. National Medical Research Center for Preventive Medicine; Moscow Russia

4. Novartis Pharmaceuticals Corporation; East Hanover NJ USA

5. Alcon Laboratories, Inc.; Fort Worth TX USA

Funder

Novartis Pharmaceuticals Corporation

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jch.13153/fullpdf

Reference32 articles.

1. Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association;Mozaffarian;Circulation,2016

2. World Health Organization (WHO) World Health Statistics 2012 http://www.who.int/gho/publications/world_health_statistics/EN_WHS2012_Full.pdf

3. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013;Forouzanfar;Lancet,2015

4. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries;Mills;Circulation,2016

5. CDC/NCHS, Health 2014 Data from the National Health and Nutrition Examination Survey (NHANES). https://www.cdc.gov/nchs/data/hus/hus14.pdf#060

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Benefit of Sacubitril/Valsartan for Hypertensive Patients in Daily Practice and Predictors of Its Antihypertensive Effect;Circulation Reports;2024-07-10

2. Efficacy and Safety of Sacubitril/Valsartan in Adverse Cardiovascular Event Reduction and Hypertension Control Among Asians: A Systematic Review and Meta-analysis of Randomized Controlled Trials;Philippine Journal of Cardiology;2024-06-15

3. Efficacy of angiotensin receptor blockers for nocturnal blood pressure reduction: a systematic review and meta-analysis;Annals of Medicine;2024-06-03

4. Comparison of sacubitril/valsartan with olmesartan for hypertension: A meta-analysis of randomized controlled trials;Medicine;2024-04-05

5. Sacubitril/valsartan reversal of left ventricular remodeling is associated with improved hemodynamics in resistant hypertension;Hellenic Journal of Cardiology;2024-04